<https://rdf.molmedb.upol.cz/reference/ref1282> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM16883>,
		<https://rdf.molmedb.upol.cz/transporter/target69>;
	<http://purl.org/ontology/bibo/pmid> "19836247"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM15110>,
		<https://identifiers.org/molmedb/MM00474>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmc.2009.09.023"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ.: Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles. Bioorg Med Chem, Volume 17 (22), 2009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource> .
<https://rdf.molmedb.upol.cz/transporter/tra31493> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1282> .
<https://rdf.molmedb.upol.cz/transporter/tra31545> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1282> .
<https://rdf.molmedb.upol.cz/transporter/tra31537> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1282> .